Lipocalin 2 deactivates macrophages and worsens pneumococcal pneumonia outcomes
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Macrophages play a key role in responding to pathogens and initiate an inflammatory response to combat microbe multiplication. Deactivation of macrophages facilitates resolution of the inflammatory response. Deactivated macrophages are characterized by an immunosuppressive phenotype, but the lack of unique markers that can reliably identify these cells explains the poorly defined biological role of this macrophage subset. We identified lipocalin 2 (LCN2) as both a marker of deactivated macrophages and a macrophage deactivator. We show that LCN2 attenuated the early inflammatory response and impaired bacterial clearance, leading to impaired survival of mice suffering from pneumococcal pneumonia. LCN2 induced IL-10 formation by macrophages, skewing macrophage polarization in a STAT3-dependent manner. Pulmonary LCN2 levels were tremendously elevated during bacterial pneumonia in humans, and high LCN2 levels were indicative of a detrimental outcome from pneumonia with Gram-positive bacteria. Our data emphasize the importance of macrophage deactivation for the outcome of pneumococcal infections and highlight the role of LCN2 and IL-10 as determinants of macrophage performance in the respiratory tract.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It should be noted, however, that Lcn2 exerts contrasting effects depending on the pathogen and tissue localization, improving or mitigating resistance to infection.For example, Lcn2 aggravates the outcome of Streptococcus pneumoniae infection [134] through a immunomodulatory effect possibly acting via regulation of Fe metabolism or another not yet fully elucidated pathway [135,136].”
From The Iron age of host–microbe interactions (2015) · cites this paper as [134]
In the citing paper
“LCN2 skews macrophages into an anti-inflammatory phenotype by increasing the formation of IL-10”
From Iron in immune cell function and host defense (2021) · cites this paper as [47]
In the citing paper
“extracellular bacteria may benefit from the action of LCN2, as its expression negatively affects the course of infections with S. pneumoniae”
From Iron in immune cell function and host defense (2021) · cites this paper as [47]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144 · cited 3×
“In vitro, macrophages polarize to proinflammatory, classically activated M1 macrophages in the presence of IFN-γ and LPS, and to alternatively activated, antiinflammatory M2 macrophages in the presence of IL-4 and/or IL-13 (2, 8, 9).”
The chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534 · cited 1×
“Deactivated macrophages are characterized by the downregulation of proinflammatory mediators and the upregulation of antiinflammatory cytokines such as IL-10 (10).”
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189 · cited 7×
“( D and E ) BMDMs were polarized with M1 (10 ng/ml LPS, 200 U/ml IFN-γ ) or M2 (10 ng/ml IL-4 and IL-13), activated with 10 ng/ml LPS (M x ), or deactivated (M dx ) with 10 ng/ml LPS and 100 μ M dexamethasone ( D and E ) or 10 ng/ml IL-10 ( D ) for 1, 6, and 16 hours.”
InfluentialMANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528 · cited 1×
“As such, further characterizations of alternative phenotypes resulted in the discovery of novel subsets, such as regulatory, deactivated, and tumor-associated macrophages (2, 9–11).”
Protective and pathogenic functions of macrophage subsets
Murray, P. J., & Wynn, T. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3073 · Cited by 5,269 · cited 1×
“Macrophages are innate immune cells involved in the maintenance of tissue homeostasis and in the pathogenesis of diverse conditions such as metabolic, allergic, fibrotic, autoimmune, and neoplastic diseases (1).”
Transcriptional regulation of macrophage polarization: enabling diversity with identity
Lawrence, T., & Natoli, G. (2011) · Nature Reviews Immunology · doi:10.1038/nri3088 · Cited by 2,284 · cited 1×
“Upon analysis of the published LCN2 promoter (21) we noticed NF-κ B binding sites, but also glucocorticoid response elements and several binding sites for transcription factors critically involved in the polarization of M2 macrophages (22), such as STAT3, CREB, and C/EBP β .”
Conditional gene targeting in macrophages and granulocytes using LysMcre mice
Clausen, B. E., Burkhardt, C., Reith, W., Renkawitz, R., & Förster, I. (1999) · Transgenic Research · doi:10.1023/a:1008942828960 · Cited by 2,098 · cited 1×
“LysMCre/Cre mice (47) were bred to STAT3flox/flox”
Stein, M., Keshav, S., Harris, N., & Gordon, S. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.1.287 · Cited by 1,960 · cited 1×
“In vitro, macrophages polarize to proinflammatory, classically activated M1 macrophages in the presence of IFN-γ and LPS, and to alternatively activated, antiinflammatory M2 macrophages in the presence of IL-4 and/or IL-13 (2, 8, 9).”
Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron
Flo, T. H., Smith, K. D., Sato, S., Rodriguez, D. J., Holmes, M. A., Strong, R. K., Akira, S., & Aderem, A. (2004) · Nature · doi:10.1038/nature03104 · Cited by 1,877 · cited 3×
“Lipocalin 2 (LCN2) (12, 13), also known as neutrophil gelatinase-associated lipocalin, is a mammalian protein expressed by myeloid and epithelial cells in response to TLR activation during infections (14, 15).”
The Isolation and Characterization of Murine Macrophages
Zhang, X., Goncalves, R., & Mosser, D. M. (2008) · Current Protocols in Immunology · doi:10.1002/0471142735.im1401s83 · Cited by 1,536
Research works printed but not linked: 1
- Zhang, 2008, Curr Protoc Immunol., Chapter 14, Unit14.1
Cited by
Horckmans, M., Ring, L., Duchene, J., Santovito, D., Schloss, M. J., Drechsler, M., Weber, C., Soehnlein, O., & Steffens, S. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw002 · Cited by 727
“Neutrophil gelatinase-associated lipocalin is released by activated neutrophils from specific granules, but also from other cells including macrophages, ischaemic cardiomyocytes, or injured kidney epithelial cells in acute renal injury.31 –33 In the setting of Streptococcus pneumonia infection, it was recently shown t…”
BackgroundInfluentialLipocalin 2: an emerging player in iron homeostasis and inflammation
Xiao, X., Yeoh, B. S., & Vijay-Kumar, M. (2017) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071816-064559 · Cited by 426
Lipocalin 2 protects from inflammation and Tumorigenesis associated with gut microbiota alterations
Moschen, A. R., Gerner, R. R., Wang, J., Klepsch, V., Adolph, T. E., Reider, S. J., Hackl, H., Pfister, A., Schilling, J., Moser, P. L., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.03.007 · Cited by 375
Lipocalin-2: A Master Mediator of Intestinal and Metabolic Inflammation
Moschen, A. R., Adolph, T. E., Gerner, R. R., Wieser, V., & Tilg, H. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2017.01.003 · Cited by 359
Iron at the interface of immunity and infection
Nairz, M., Haschka, D., Demetz, E., & Weiss, G. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00152 · Cited by 325
Self-citation
Metadata
- Authors
- Warszawska, J. M., Gawish, R., Sharif, O., Sigel, S., Doninger, B., Lakovits, K., Mesteri, I., Nairz, M., Boon, L., Spiel, A., Fuhrmann, V., Strobl, B., Müller, M., Schenk, P., Weiss, G., & Knapp, S.
- Affiliations
- Austrian Academy of Sciences (AT)
- Innsbruck Medical University (AT)
- Polpharma Biologics (Netherlands) (NL)
- Medical University of Vienna (AT)
- University of Veterinary Medicine Vienna (AT)
- Corresponding author
- Knapp, Sylvia
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2013-07-01
- Volume
- 123
- Issue
- 8
- Pages
- 3363-3372
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3726165
- OpenAlex
- W2029434160
- Cited by
- 148
- References
- 56
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 12 · 2023: 13 · 2022: 10 · 2021: 10 · 2020: 13 · 2019: 9 · 2018: 11 · 2017: 11 · 2016: 13 · 2015: 14 · 2014: 21
- FWCI
- 8.85
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Austrian Science Fund (SFB‐F28, I 289)
- Universität Wien
- Medizinische Universität Wien
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Keywords
- neutrophil gelatinase-associated lipocalin, macrophage deactivation, pneumococcal pneumonia, Streptococcus pneumoniae, IL-10, STAT3 signaling, macrophage polarization, bacterial clearance, Gram-positive bacterial infections, immunosuppression, lung inflammation
- MeSH terms
- Lipocalin-2, Acute-Phase Proteins, Adult, Aged, Animals, Female, Humans, Immune Tolerance, Lung, Macrophage Activation, Male, Mice, Inbred C57BL, Middle Aged, Pneumonia, Pneumococcal, Proto-Oncogene Proteins, Oncogene Proteins, Macrophages, Alveolar, Interleukin-10, Transplantation Chimera, Mice, Knockout, Mice, Lipocalins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lipocalin 2 deactivates macrophages and worsens pneumococcal pneumonia outcomes. https://app.cochat.ai/papers/10.1172/jci67911
- The paper
- Warszawska, J. M., Gawish, R., Sharif, O., Sigel, S., Doninger, B., Lakovits, K., Mesteri, I., Nairz, M., Boon, L., Spiel, A., Fuhrmann, V., Strobl, B., Müller, M., Schenk, P., Weiss, G., & Knapp, S. (2013). Lipocalin 2 deactivates macrophages and worsens pneumococcal pneumonia outcomes. Journal of Clinical Investigation. https://doi.org/10.1172/jci67911
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.